CO6460741A2 - STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) -3,3-DIMETIL-BUTIRAMIDA - Google Patents

STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) -3,3-DIMETIL-BUTIRAMIDA

Info

Publication number
CO6460741A2
CO6460741A2 CO11153611A CO11153611A CO6460741A2 CO 6460741 A2 CO6460741 A2 CO 6460741A2 CO 11153611 A CO11153611 A CO 11153611A CO 11153611 A CO11153611 A CO 11153611A CO 6460741 A2 CO6460741 A2 CO 6460741A2
Authority
CO
Colombia
Prior art keywords
dimetil
butiramida
morfolin
fenil
stable forms
Prior art date
Application number
CO11153611A
Other languages
Spanish (es)
Inventor
Svend Treppendahl
Karin Liltorp
De Diego Heidi Lopez
Original Assignee
H Lundbeck & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6460741(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck & Co As filed Critical H Lundbeck & Co As
Publication of CO6460741A2 publication Critical patent/CO6460741A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

La presente invención se refiere a formas cristalinas particulares de N-(2,6-dimetil-4-morfolin-4-il-fenil)-3,3-dimetil-butiramida con propiedades mejoradas y un método para tratar una enfermedad seleccionada de trastornos convulsivos, esquizofrenia, trastornos depresivos y trastornos de espectro bipolar.The present invention relates to particular crystalline forms of N- (2,6-dimethyl-4-morpholin-4-yl-phenyl) -3,3-dimethyl-butyramide with improved properties and a method of treating a disease selected from disorders seizures, schizophrenia, depressive disorders and bipolar spectrum disorders.

CO11153611A 2009-05-11 2011-11-11 STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) -3,3-DIMETIL-BUTIRAMIDA CO6460741A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11

Publications (1)

Publication Number Publication Date
CO6460741A2 true CO6460741A2 (en) 2012-06-15

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11153611A CO6460741A2 (en) 2009-05-11 2011-11-11 STABLE FORMS OF N- (2,6-DIMETIL-4-MORFOLIN-4-IL-FENIL) -3,3-DIMETIL-BUTIRAMIDA

Country Status (23)

Country Link
EP (1) EP2430008A2 (en)
JP (1) JP2012526152A (en)
KR (1) KR20120022934A (en)
CN (1) CN102459208A (en)
AR (1) AR076556A1 (en)
AU (1) AU2010246724B2 (en)
BR (1) BRPI1013930A2 (en)
CA (1) CA2761383A1 (en)
CL (1) CL2011002814A1 (en)
CO (1) CO6460741A2 (en)
CR (1) CR20110590A (en)
DO (1) DOP2011000351A (en)
EA (1) EA201171381A1 (en)
GE (1) GEP20146006B (en)
IL (1) IL216148A0 (en)
MA (1) MA33351B1 (en)
MX (1) MX2011011885A (en)
NZ (1) NZ596738A (en)
SG (1) SG175968A1 (en)
TN (1) TN2011000557A1 (en)
TW (1) TW201041857A (en)
WO (1) WO2010130260A2 (en)
ZA (1) ZA201108112B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
JP5419691B2 (en) * 2006-08-23 2014-02-19 バレアント ファーマシューティカルズ インターナショナル Derivatives of 4- (N-azacycloalkyl) anilide as potassium channel modulators
JP2011513196A (en) * 2007-08-01 2011-04-28 ハー・ルンドベック・アクチエゼルスカベット Use of a KCNQ potassium channel opener to alleviate symptoms of or treat a disorder or condition in which the dopaminergic system is disrupted

Also Published As

Publication number Publication date
ZA201108112B (en) 2013-01-30
TW201041857A (en) 2010-12-01
BRPI1013930A2 (en) 2019-09-24
MX2011011885A (en) 2011-12-06
CL2011002814A1 (en) 2012-04-13
TN2011000557A1 (en) 2013-05-24
DOP2011000351A (en) 2012-01-31
MA33351B1 (en) 2012-06-01
JP2012526152A (en) 2012-10-25
SG175968A1 (en) 2011-12-29
WO2010130260A3 (en) 2011-06-16
EP2430008A2 (en) 2012-03-21
WO2010130260A9 (en) 2012-10-18
CA2761383A1 (en) 2010-11-18
IL216148A0 (en) 2012-01-31
CR20110590A (en) 2012-02-22
EA201171381A1 (en) 2012-05-30
WO2010130260A2 (en) 2010-11-18
AR076556A1 (en) 2011-06-22
AU2010246724A1 (en) 2011-12-08
AU2010246724B2 (en) 2013-03-21
CN102459208A (en) 2012-05-16
NZ596738A (en) 2013-04-26
GEP20146006B (en) 2014-01-10
KR20120022934A (en) 2012-03-12

Similar Documents

Publication Publication Date Title
SMT201400179B (en) 1,2,5-Ossadiazoles as indoleamine 2,3-dioxygenase inhibitors
AR061311A1 (en) PROCESSES TO PREPARE CINACALCET CHLORHYDRATE AND POLYMORPHIC FORMS OF THE SAME
ECSP13012985A (en) REPLACED PYRIMIDINES OF DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE, COMPOSITIONS OF THE SAME AND METHODS OF TREATMENT WITH THE SAME
EA201270012A1 (en) SUBLINGUAL APOMORFIN
UY34545A (en) NOVEDOSE DIHYDROPIRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME FOR THE TREATMENT OF INFLAMMATORY DISORDERS.
UY34352A (en) 3-PIRIMIDIN-4-IL-OXAZOLIDIN-2-ONAS AS INHIBITORS OF THE MUTANT HDI
EA201290677A1 (en) CONNECTIONS OF REVERSE AMIDA AS PROTIN-DEACETYLASE INHIBITORS AND METHODS
BR112022003505A2 (en) Compositions and methods for treating repetitive DNA-associated disorders
EA201101686A1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF CMT AND RELATED DISORDERS
BR112012000735A2 (en) "compound methods, kits and sets"
MA32811B1 (en) NEW COMPOUNDS
BR112015028853A2 (en) DETERGENT COMPOSITION WITH LOW PH
EA201170356A1 (en) POLYMORPHIC AND AMORPHOUS FORMS OF LACOSAMIDE AND AMORPHOUS COMPOSITIONS
CR8341A (en) A COMPOSITION AND TREATMENT METHOD FOR UROGENITAL CONDITIONS
EA201500403A1 (en) COMPOUNDS ACTIVATING TELOMERASE AND METHODS OF THEIR APPLICATION
CL2012002540A1 (en) Agomelatine Hydrochloride Hydrate; crystalline form; Preparation method; pharmaceutical composition; and its use for the treatment of sleep disorders, stress, anxiety, major depression, cardiovascular diseases, among others.
CO6660435A2 (en) A crystalline form of (r) -7- chloro-n- (quinuclidin -3-yl) benzo [b] thiophene-2-carboxamide hydrochloride monohydrate
EA201792604A1 (en) AUTOTAXIN INHIBITORS AND THEIR APPLICATIONS
EA200802072A1 (en) LIKOPIN FOR THE TREATMENT OF INFRINGEMENT OF SUBSTANCES
CL2012001031A1 (en) 2-Oxo-1-pyrrolidinyl-imidazothiadiazole derived compounds; pharmaceutical composition comprising them; useful for the treatment of epilepsy, neurological disorders, among others.
MX2012007332A (en) Mglu2 agonists.
BR112012004652A2 (en) concentrated solution compositions comprising group vi metal, group viii metal and phosphorus and forming process
CR20130106A (en) NEW TRPV3 MODULATORS
BR112015007555A2 (en) fluoropolyether based elastomers having low glass transition temperature
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea

Legal Events

Date Code Title Description
FC Application refused